Eyexora to Participate in the Citizens Virtual Private Ophthalmology Summit
Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model,
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, today announced that Theresa Heah, MD, MBA, Chief Executive Officer and Vice Chair, will participate in a fireside chat discussion at the Citizens Virtual Private Ophthalmology Summit on Thursday, September 17, 2026 at 2:30 PM EDT.
About Eyexora
Eyexora is a global ophthalmology company pioneering a hub-and-spoke model to accelerate innovation in eye care. By centralizing scientific, clinical, regulatory, and commercial expertise, Eyexora advances a diversified pipeline of therapies and devices through focused subsidiaries, to reduce risk, improve efficiency, and scale impact.
Founded by leaders with decades of ophthalmology experience and a track record of more than 30 successful company and product launches, Eyexora partners with clinician-scientists and research institutes worldwide to bring transformative eye care solutions to patients faster and smarter. For more information, visit www.eyexora.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260910353780/en/
Media gallery
